Progress in a tough climate

Alliance Pharma has adopted a buy-and-build strategy to evolve through a series of 28 acquisitions into a profitable, cash generative, specialty pharma business. The acquisition of part of the dermatology and woundcare products from Sinclair IS Pharma was transformational, broadly doubling the size of the company at a stroke, providing a more internationally-oriented business with the potential to exploit growth opportunities of its existing products. Moreover, it has made the enlarged group ...